Filter posts

Making it Personal

The “valley of death” between drug discovery and the development and provision of therapy is …

Ensuring the Safety and Commercial Success of Biosimilars in the United States

The forthcoming arrival of biosimilars into the U.S has spurred debate over the approaches that …

Fighting Prostate Cancer with Immunotherapy

Advaxis and UC San Francisco join forces to develop and test a range of novel …

RSV Vaccines

Respiratory syncytial virus (RSV) is a major pathogen in infants, children, and adults. According to …

Differences Between Establishing Value for Approval Versus Coverage?

Yes, but maybe not irreconcilable. Many of the educational sessions on the first day of …

Reimbursement Considerations for Early Stage Companies

Panelists at Tuesday’s breakout session – Reimbursement Considerations for Early Stage Companies – overwhelmingly agreed …

Integrate and Collaborate to Drive Advancements in Oncology Treatments

Scientific innovation and exploration have driven exciting changes in the pharmaceutical industry’s understanding of cancer, …

Syringes for Clinical Trials

Today’s pharmaceutical and biotechnology companies are under pressure to remain competitive. To do so, they …

Transforming Healthcare through Digital Innovation

Imagine being connected to expert health coaches on a daily basis instead of only at …

Precision Drugs for Bad Bugs

Awareness is high that antibiotic resistance is a critical problem, but many still don’t appreciate …